EUVIMEDEUVIMED entdecken
Crossref

Targeting of Low‐Immunogenic Poly(ethylene glycol) Nanoparticles for Photothermal‐Enhanced Immunotherapy

Mengqi Li, Zhiliang Gao, Ning Wang, Kanaparedu P C Sekhar, Jingcheng Hao, Jiwei Cui iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202402954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Mengqi Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Colloid and Interface Chemistry of the Ministry of Education, School of Chemistry and Chemical Engineering, Shandong University, Ji…. Hauptthemen laut MEDLINE: Polyethylene Glycols, Nanoparticles, Immunotherapy, Photothermal Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, International Cooperation Project of Shandong Province, Center for International Cooperation and Disciplinary Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The assembly of low‐immunogenic poly(ethylene glycol) nanoparticles (PEG NPs) for targeted delivery of therapeutics (i.e., mitoxantrone and imidazoquinoline) and improved photothermal‐immunotherapy is reported. The targeted PEG NPs incorporating targeting molecules of hyaluronic acid are engineered via the templating of metal–organic frameworks, which can circumvent accelerated blood clearance and exhibit prolonged circulation time as well as improved accumulation of therapeutics at tumor sites. The targeted delivery of mitoxantrone under laser radiation induces immunogenic cell death of tumor cells, which is combined with toll‐like receptor 7/8 agonists of imidazoquinoline to trigger immune responses of cytotoxic T lymphocytes for the eradication of tumor cells. Furthermore, the treatment can induce tumor‐specific immune responses that inhibit metastatic lung tumor growth. This reported targeted PEG NPs provide a rational design for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyethylene GlycolsNanoparticlesImmunotherapyPhotothermal TherapyAnimalsHumansMiceCell Line, TumorPhototherapyHyaluronic Acid

Stichwörter der Autor:innen

immunogenic cell deathimmunotherapylow‐immunogenicitypoly(ethylene glycol)targeted delivery

Substanzen

Polyethylene GlycolsHyaluronic Acid

Autor:innen und Institutionen

  • Key Laboratory of Colloid and Interface Chemistry of the Ministry of Education, School of Chemistry and Chemical Engineering, Shandong University, Jinan, 250100, China.
  • Shandong Key Laboratory of Targeted Drug Delivery and Advanced Pharmaceutics, Shandong University, Jinan, 250100, China.

ORCID-Profile: Jiwei Cui

Förderung

  • National Natural Science Foundation of China
  • International Cooperation Project of Shandong Province
  • Center for International Cooperation and Disciplinary Innovation
  • Instrument Improvement Funds of Shandong University Public Technology Platform

Zitieren

APA

Li, M., Gao, Z., Wang, N., Sekhar, K. P. C., Hao, J., & Cui, J. (2025). Targeting of Low‐Immunogenic Poly(ethylene glycol) Nanoparticles for Photothermal‐Enhanced Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402954

Vancouver

Li M, Gao Z, Wang N, Sekhar KPC, Hao J, Cui J. Targeting of Low‐Immunogenic Poly(ethylene glycol) Nanoparticles for Photothermal‐Enhanced Immunotherapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402954

BibTeX
@article{Li2025,
  author = {Li, Mengqi and Gao, Zhiliang and Wang, Ning and Sekhar, Kanaparedu P C and Hao, Jingcheng and Cui, Jiwei},
  title = {Targeting of Low‐Immunogenic Poly(ethylene glycol) Nanoparticles for Photothermal‐Enhanced Immunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202402954}
}
Kostenlos starten →